Pain
Latest News
Positive top-line results for cannabinoid-based med for nerve pain
“Through this rigorously designed study, we have demonstrated that ZLT-L-007 is a safe, effective, and well-tolerated alternative for patients who...
Latest News
Exercise and empathy can help back pain patients in primary care
Recent research suggests limited pain relief from analgesics and antidepressants, but patients report that doctors’ behavior makes a difference in...
News
Researchers locate signals in brain related to chronic pain
“Such patterns of brain activity could serve as biomarkers to guide diagnosis and treatment for millions of people with shooting or burning...
Latest News
FDA OKs spinal cord stimulation devices for chronic back pain
The indication for the devices now includes treatment of chronic back pain in patients who have not had, or are not eligible for, back surgery.
Applied Evidence
Medication-assisted recovery for opioid use disorder: A guide
Considering offering medical intervention for OUD to reduce mortality? It’s essential to understand the clinical benefits, limitations, and...
Guidance for Practicing Primary Care
Thoughts on the CDC update on opioid prescribing guidelines
While the guidelines do a great job recommending how to prescribe opioids, they do not go into any depth discussing other treatment options.
Latest News
Watching feasible for asymptomatic kidney stones
Urologists can be comfortable watching small stones (2.4 mm or less in size, but any significantly larger than that (7-8 mm) should be managed...
Latest News
Interdisciplinary program reduced pediatric pain without pharmacology
Participating in an outpatient program also had a significant positive effect on health-related quality of life for patients and families
From the Journals
Cancer pain declines with cannabis use
Lower use of other meds was also seen in patients who used cannabis.
Conference Coverage
Head-to-head comparison of migraine meds reveals top options
“To the best of our knowledge, this is the first study that simultaneously compared multiple acute migraine medications using a Big Data analysis...
News
FDA expands atogepant approval to include chronic migraine
The approval makes atogepant the first, and only, oral CGRP receptor antagonist approved to prevent migraine across frequencies, including...